MedPath

Lidocaine and Ketamine Versus Standard Care on Acute and Chronic Pain

Not Applicable
Terminated
Conditions
Pain
Nausea
Interventions
Drug: Lidocaine/Ketamine
Other: placebo
Registration Number
NCT00720330
Lead Sponsor
The Cleveland Clinic
Brief Summary

The investigators are conducting this study to find out if intravenous (injected through the vein) infusion of lidocaine and ketamine administered with general anesthesia is as effective as a paravertebral block in lessening pain after surgery and that both of these techniques are superior to general anesthesia alone in reducing pain immediately after surgery and in the long-term.

Detailed Description

Participants will be randomized into one of three study groups; Group 1 - Paravertebral Group - ropivacaine is injected near the spine before surgery. Midazolam and fentanyl are administered intravenously for sedation. Group 2 - Lidocaine/Ketamine - General anesthesia with lidocaine and ketamine administered intravenously throughout your surgery and for 60 minutes after surgery. Group 3 - General Anesthesia Alone. General anesthesia with placebo administered intravenously throughout surgery and for 60 minutes after surgery. All participants will rate their pain on a scale from 0 to 10 after surgery and on days 1 and 2 after surgery. Participants are called 3 and 6 months after surgery for pain and quality of life assessments

Recruitment & Eligibility

Status
TERMINATED
Sex
Male
Target Recruitment
12
Inclusion Criteria
  • Age greater than 18 and less than 75 years
  • Male
  • Unilateral inguinal hernia scheduled for elective open repair
Exclusion Criteria
  • Incarcerated hernia or urgent procedure
  • Reoperation (recurrent hernia)
  • Contraindication to regional anesthesia such as:
  • Coagulopathy
  • Infection at the site of needle insertion
  • Pre-existing chronic pain (at any site) requiring treatment
  • Contraindication to any study medication (local anesthetic or ketamine)
  • History of significant Axis I psychiatric disease (major depressive disorder,bipolar disorder, schizophrenia, etc.)
  • Significant hepatic (ALT or AST > 2 times normal) or renal (serum creatinine > 2 mg/dl) impairment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Lidocaine/ketamineLidocaine/KetamineParticipant will receive general anesthesia through the vein before surgery. Lidocaine and ketamine will be administered intravenously throughout surgery and for 60 minutes after surgery.
PlaceboplaceboGeneral anesthesia plus placebo. Placebo will be administered intravenously until 60 minutes after surgery
RopivacaineropivacaineParavertebral Group - A local anesthetic (ropivacaine) will be injected near the spine before surgery. Participants will also receive midazolam and fentanyl intravenously (through your vein) for sedation
Primary Outcome Measures
NameTimeMethod
Postoperative Opioid Consumption in Oral Oxycodone Equivalents2 days after surgery

The cumulative opioid consumption after surgery until the end of second postoperative day.

Secondary Outcome Measures
NameTimeMethod
Pre- and Intra-operative Opioid Consumption in Fentanyl EquivalentsFrom admission to the end of surgery

The cumulative opioid consumption is calculated as fentanyl equivalent

Postoperative NauseaAfter surgery until the second postoperative day.

Number of patients who had postoperative nausea or vomiting were recorded.

Time From the End of Surgery to Readiness for Hospital Discharge.Until hospital discharge, assessed up to 6 months
Pain Scores on Numerical Rating ScaleAfter surgery until the second postoperative mornings.

Numerical Rating Scales is a measurement of pain ranging from 0 to 10 (11 point scale), where 0 is equal to no pain and 10 is equal to worst possible pain. Pain scores were measured in PACU, first and second postoperative mornings.

Trial Locations

Locations (1)

Cleveland Clinic/Hillcrest Hospital

🇺🇸

Mayfield Heights, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath